Aytu BioPharma Inc (AYTU)
1.54
-0.20
(-11.75%)
USD |
NASDAQ |
Nov 14, 16:00
1.54
0.00 (0.00%)
After-Hours: 19:59
Aytu BioPharma Total Assets (Quarterly): 118.10M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 118.10M |
| March 31, 2024 | 128.86M |
| December 31, 2023 | 131.25M |
| September 30, 2023 | 132.89M |
| June 30, 2023 | 136.46M |
| March 31, 2023 | 147.22M |
| December 31, 2022 | 141.44M |
| September 30, 2022 | 150.00M |
| June 30, 2022 | 137.62M |
| March 31, 2022 | 168.83M |
| December 31, 2021 | 223.82M |
| September 30, 2021 | 227.73M |
| June 30, 2021 | 265.67M |
| March 31, 2021 | 271.56M |
| December 31, 2020 | 166.74M |
| September 30, 2020 | 141.27M |
| June 30, 2020 | 153.29M |
| March 31, 2020 | 158.95M |
| December 31, 2019 | 74.48M |
| September 30, 2019 | 31.02M |
| June 30, 2019 | 34.72M |
| March 31, 2019 | 38.34M |
| December 31, 2018 | 42.40M |
| September 30, 2018 | 17.98M |
| June 30, 2018 | 21.06M |
| Date | Value |
|---|---|
| March 31, 2018 | 23.37M |
| December 31, 2017 | 18.86M |
| September 30, 2017 | 21.25M |
| June 30, 2017 | 15.00M |
| March 31, 2017 | 15.92M |
| December 31, 2016 | 21.51M |
| September 30, 2016 | 20.20M |
| June 30, 2016 | 24.34M |
| March 31, 2016 | 21.99M |
| December 31, 2015 | 24.41M |
| September 30, 2015 | 21.36M |
| June 30, 2015 | 18.19M |
| March 31, 2015 | 10.20M |
| February 28, 2015 | 0.008M |
| November 30, 2014 | 0.0112M |
| August 31, 2014 | 0.0055M |
| May 31, 2014 | 0.0135M |
| February 28, 2014 | 0.0056M |
| November 30, 2013 | 0.0072M |
| August 31, 2013 | 0.0097M |
| May 31, 2013 | 0.0094M |
| February 28, 2013 | 0.0131M |
| November 30, 2012 | 0.0119M |
| August 31, 2012 | 0.0126M |
| May 31, 2012 | 0.014M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.48M
Minimum
Dec 2019
271.56M
Maximum
Mar 2021
161.90M
Average
147.22M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| enVVeno Medical Corp | 50.39M |
| Bristol-Myers Squibb Co | 93.67B |
| Telesis Bio Inc | 52.73M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 90.38M |
| Shareholders Equity (Quarterly) | 27.72M |
| Debt to Equity Ratio | 0.5459 |
| Current Ratio | 0.9946 |
| Net Debt Paydown Yield | 11.43% |